438 related articles for article (PubMed ID: 26735578)
1. A MALAT1/HIF-2α feedback loop contributes to arsenite carcinogenesis.
Luo F; Sun B; Li H; Xu Y; Liu Y; Liu X; Lu L; Li J; Wang Q; Wei S; Shi L; Lu X; Liu Q; Zhang A
Oncotarget; 2016 Feb; 7(5):5769-87. PubMed ID: 26735578
[TBL] [Abstract][Full Text] [Related]
2. The lncRNA MALAT1, acting through HIF-1α stabilization, enhances arsenite-induced glycolysis in human hepatic L-02 cells.
Luo F; Liu X; Ling M; Lu L; Shi L; Lu X; Li J; Zhang A; Liu Q
Biochim Biophys Acta; 2016 Sep; 1862(9):1685-95. PubMed ID: 27287256
[TBL] [Abstract][Full Text] [Related]
3. Involvement of HIF-2α-mediated inflammation in arsenite-induced transformation of human bronchial epithelial cells.
Xu Y; Zhao Y; Xu W; Luo F; Wang B; Li Y; Pang Y; Liu Q
Toxicol Appl Pharmacol; 2013 Oct; 272(2):542-50. PubMed ID: 23811328
[TBL] [Abstract][Full Text] [Related]
4. Blockade of p53 by HIF-2α, but not HIF-1α, is involved in arsenite-induced malignant transformation of human bronchial epithelial cells.
Xu Y; Li Y; Pang Y; Ling M; Shen L; Jiang R; Zhao Y; Zhou J; Wang X; Liu Q
Arch Toxicol; 2012 Jun; 86(6):947-59. PubMed ID: 22447124
[TBL] [Abstract][Full Text] [Related]
5. The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy.
Yuan P; Cao W; Zang Q; Li G; Guo X; Fan J
Biochem Biophys Res Commun; 2016 Sep; 478(3):1067-73. PubMed ID: 27524242
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
Sandlund J; Ljungberg B; Wikström P; Grankvist K; Lindh G; Rasmuson T
Acta Oncol; 2009; 48(6):909-14. PubMed ID: 19322701
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
8. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
[TBL] [Abstract][Full Text] [Related]
9. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
[TBL] [Abstract][Full Text] [Related]
10. EMT and stem cell-like properties associated with HIF-2α are involved in arsenite-induced transformation of human bronchial epithelial cells.
Xu Y; Li Y; Pang Y; Ling M; Shen L; Yang X; Zhang J; Zhou J; Wang X; Liu Q
PLoS One; 2012; 7(5):e37765. PubMed ID: 22662215
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-2alpha regulates the expression of TRAIL receptor DR5 in renal cancer cells.
Mahajan S; Dammai V; Hsu T; Kraft AS
Carcinogenesis; 2008 Sep; 29(9):1734-41. PubMed ID: 18544564
[TBL] [Abstract][Full Text] [Related]
12. The accumulations of HIF-1α and HIF-2α by JNK and ERK are involved in biphasic effects induced by different levels of arsenite in human bronchial epithelial cells.
Xu Y; Li Y; Li H; Pang Y; Zhao Y; Jiang R; Shen L; Zhou J; Wang X; Liu Q
Toxicol Appl Pharmacol; 2013 Jan; 266(2):187-97. PubMed ID: 23194660
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.
Cannito S; Turato C; Paternostro C; Biasiolo A; Colombatto S; Cambieri I; Quarta S; Novo E; Morello E; Villano G; Fasolato S; Musso T; David E; Tusa I; Rovida E; Autelli R; Smedile A; Cillo U; Pontisso P; Parola M
Oncotarget; 2015 Feb; 6(4):2206-21. PubMed ID: 25544768
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.
Zhai W; Sun Y; Jiang M; Wang M; Gasiewicz TA; Zheng J; Chang C
Oncogene; 2016 Sep; 35(37):4866-80. PubMed ID: 26973243
[TBL] [Abstract][Full Text] [Related]
15. HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma.
Cao M; Gao J; Zhou H; Huang J; You A; Guo Z; Fang F; Zhang W; Song T; Zhang T
Tumour Biol; 2016 Feb; 37(2):1651-62. PubMed ID: 26307391
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
[TBL] [Abstract][Full Text] [Related]
17. Cross talk between oxidative stress and hypoxia via thioredoxin and HIF-2α drives metastasis of hepatocellular carcinoma.
Cao MQ; You AB; Cui W; Zhang S; Guo ZG; Chen L; Zhu XD; Zhang W; Zhu XL; Guo H; Deng DJ; Sun HC; Zhang T
FASEB J; 2020 Apr; 34(4):5892-5905. PubMed ID: 32157720
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML.
Forristal CE; Brown AL; Helwani FM; Winkler IG; Nowlan B; Barbier V; Powell RJ; Engler GA; Diakiw SM; Zannettino AC; Martin S; Pattabiraman D; D'Andrea RJ; Lewis ID; Levesque JP
Leukemia; 2015 Oct; 29(10):2075-85. PubMed ID: 25921247
[TBL] [Abstract][Full Text] [Related]
19. HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma.
Geis T; Döring C; Popp R; Grossmann N; Fleming I; Hansmann ML; Dehne N; Brüne B
Exp Cell Res; 2015 Feb; 331(1):46-57. PubMed ID: 25489981
[TBL] [Abstract][Full Text] [Related]
20. The inhibition of HIF-2α on the ATM/Chk-2 pathway is involved in the promotion effect of arsenite on benzo(a)pyrene-induced cell transformation.
Pang Y; Xu Y; Li H; Li Y; Zhao Y; Jiang R; Shen L; Zhou J; Wang X; Liu Q
Toxicol Lett; 2013 Apr; 218(2):105-17. PubMed ID: 23333640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
